Dunhill Financial, LLC

Position in LLY — ELI LILLY & Co

CIK 1948904 LONDON, X0

Position in LLY

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$875,583

+$252,899 QoQ

Shares Held

730

+7.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.47%

of 13F equity value

Holder Rank

#3,257

of 4,605 holders

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Dunhill Financial, LLC holds $6,908,274 across 15 Drug Manufacturers - General names. LLY ranks #4 (12.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PFE	Pfizer Inc	113,506	$2,733,224
2	ABBV	AbbVie Inc.	4,061	$1,021,910
3	JNJ	Johnson & Johnson	3,664	$930,546
4	LLY	ELI LILLY & Co This page	730	$875,583
5	AMGN	Amgen Inc	1,716	$621,397
6	NVS	Novartis AG	1,303	$204,206
7	BMY	Bristol Myers Squibb Co	1,889	$108,844
8	NVO	Novo Nordisk A S	1,972	$94,537

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$875,583	730	+7.8%	Shares	Sole	2026-08-07
2026-03-31	$622,684	677	+24.9%	Shares	Sole	2026-05-06
2025-12-31	$582,476	542	+12.9%	Shares	Sole	2026-01-29
2025-09-30	$366,240	480	-17.5%	Shares	Sole	2025-11-12
2025-06-30	$453,686	582	+1.4%	Shares	Sole	2025-08-05
2025-03-31	$474,072	574	-1.4%	Shares	Sole	2025-04-21
2024-12-31	$449,304	582	-9.5%	Shares	Sole	2025-02-14
2024-09-30	$569,659	643	+15.0%	Shares	Sole	2024-11-15
2024-06-30	$506,107	559	-33.7%	Shares	Sole	2024-08-09
2024-03-31	$655,820	843	+0.8%	Shares	Sole	2024-05-13
2023-12-31	$487,321	836	+3.2%	Shares	Sole	2024-02-12
2023-06-30	$379,873	810	—	Shares	Sole	2023-08-23
No filing history on record for this holder in this stock.